Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
GEORGE MICHAEL W
   2. Issuer Name and Ticker or Trading Symbol
CorMedix Inc. [CRMD] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
C/O CORMEDIX INC., 1430 HIGHWAY 206, SUITE 200		 3. Date of Earliest Transaction (Month/Day/Year)
02/21/2017
(Street)

BEDMINSTER, NJ 07921		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy Common Stock) $ 2.24 02/21/2017 02/21/2017 A   40,000     (1) 02/21/2027 Common Stock 40,000 $ 0 40,000 D  
Restricted Stock Units (2) 02/21/2017 02/21/2017 A   12,232     (2)   (2) Common Stock 12,232 $ 0 12,232 D  
Phantom Stock $ 0 (3)               (3)   (3) Common Stock 3,472   3,472 D  
Phantom Stock $ 0 (3)               (3)   (3) Common Stock 4,143   4,143 D  
Stock Option (Right to Buy Common Stock) $ 2.11               (4) 04/05/2024 Common Stock 15,000   15,000 D  
Stock Option (Right to Buy Common Stock) $ 2.79               (1) 02/27/2024 Common Stock 30,000   30,000 D  
Stock Option (Right to Buy Common Stock) $ 5.62               (1) 03/01/2025 Common Stock 50,000   50,000 D  
Phantom Stock $ 0 (3)               (3)   (3) Common Stock 1,847   1,847 D  
Phantom Stock $ 0 (3)               (3)   (3) Common Stock 1,176   1,176 D  
Phantom Stock $ 0 (3)               (3)   (3) Common Stock 2,459   2,459 D  
Phantom Stock $ 0 (3)               (3)   (3) Common Stock 3,125   3,125 D  
Stock Option (Right to Buy Common Stock) $ 1.91               (1) 02/21/2026 Common Stock 90,000   90,000 D  
Phantom Stock $ 0 (3)               (3)   (3) Common Stock 3,968   3,968 D  
Phantom Stock $ 0 (3)               (3)   (3) Common Stock 2,767   2,767 D  
Phantom Stock $ 0 (3)               (3)   (3) Common Stock 4,335   4,335 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
GEORGE MICHAEL W
C/O CORMEDIX INC.
1430 HIGHWAY 206, SUITE 200
BEDMINSTER, NJ 07921		   X      

Signatures

 /s/ Alexander M. Donaldson, by Power of Attorney   02/23/2017
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) These options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
(2) Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board.
(3) Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
(4) 5,000 shares vest upon completion of the April 2014 milestone, 10,000 shares vest upon completion of another milestone by the third quarter of 2014.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.